What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Duck Viral Enteritis: Clinical Disease and Management

Introduction

Duck viral enteritis (DVE), also known as duck plague, is an acute, highly contagious viral disease affecting members of the order Anseriformes (ducks, geese, swans) and occasionally other waterfowl. The causative agent is Anatid herpesvirus 1 (AnHV-1), a member of the subfamily Alphaherpesvirinae within the family Herpesviridae [1, 2]. This disease poses a significant threat to commercial duck flocks, wild waterfowl populations, and conservation collections worldwide [34]. Understanding the clinical disease and implementing rigorous management strategies are essential for mitigating outbreaks. This article provides a comprehensive reference for veterinary professionals on the etiology, epidemiology, clinical presentation, pathology, diagnostics, treatment, and control of duck viral enteritis. For a broader overview of waterfowl pathogens, see the related article on Duck Viral Diseases: A Comprehensive Guide to Duck Plague, Duck Hepatitis, and Other Duck Viruses.

What is Ducks Disease? Defining Duck Viral Enteritis

The colloquial term "ducks disease" frequently refers to duck viral enteritis, although it can be ambiguous. DVE is defined as a herpesviral infection characterized by vascular damage, hemorrhagic lesions, and rapid mortality in susceptible waterfowl populations [1, 34]. The disease was first described in the Netherlands in the 1920s and has since been recognized in many parts of the world, including Asia, Europe, North America, and Africa [2, 35]. The etiological agent, duck enteritis virus (DEV), is antigenically distinct from other avian herpesviruses such as Marek's disease virus or infectious laryngotracheitis virus [3]. Genomic analyses have revealed considerable diversity among circulating strains, with virulence markers located across the large double-stranded DNA genome [4, 5]. A fundamental grasp of DVE is critical for differential diagnosis, which must include consideration of other viral infections such as Newcastle disease and avian influenza (see Common Viral Diseases in Poultry: Diagnosis and Differential Considerations).

Etiology

The etiological agent of DVE is Anatid herpesvirus 1, a double-stranded DNA virus with a genome of approximately 158 kb [2, 6]. The viral particle is enveloped with an icosahedral capsid and measures roughly 180 nm in diameter [32]. The genome encodes numerous structural and non-structural proteins involved in replication, virion morphogenesis, and immune evasion [7, 8, 9, 10]. The UL50 gene has been demonstrated to be essential for viral replication and pathogenesis [7]. Other genes such as UL2, UL14, UL24, LORF4, and US3 contribute to various aspects of the viral life cycle [4, 5, 8, 11, 10]. The UL2 gene product is involved in nucleotide metabolism; a novel variant with a deletion in UL2 exhibited altered pathogenicity and shedding patterns [4, 5]. The US3 protein kinase phosphorylates interferon regulatory factor 7 (IRF7) to inhibit DNA sensing signaling pathways [10]. The UL24 protein initiates K48/K63-linked polyubiquitination of IRF7, further antagonizing the innate immune response [8]. The cGAS-STING DNA-sensing pathway is also targeted by DEV to evade innate immunity [9].

DEV can be propagated in various cell cultures, including chicken embryo fibroblasts (CEF) and duck embryo fibroblasts, where cytopathic effects become evident within 48–72 hours [1, 12, 13]. The virus is relatively stable in the environment but is susceptible to lipid solvents, common disinfectants, and high temperatures [34]. Strain variation is considerable; virulent field isolates and attenuated vaccine strains have been characterized at the genomic level [1, 14, 6, 15]. Some novel variants have emerged from geese, highlighting the expanding host range [15]. Complete genome sequences are available for isolates from Bangladesh, India, China, and other regions [2, 4, 35].

Epidemiology

Duck viral enteritis occurs in both domestic and wild waterfowl populations, with disease outbreaks frequently reported in Asia, Europe, and North America [1, 34]. All ages of ducks are susceptible, but morbidity and mortality are highest in adult birds, particularly during the breeding season [34]. Transmission occurs via the fecal-oral route; the virus is shed in feces, ocular secretions, and respiratory exudates [1, 15]. Infected birds that recover can become latent carriers, intermittently shedding virus under stress [34]. The incubation period ranges from 3 to 7 days in naturally infected birds but can be extended to 14 days in experimental infections [1].

Horizontal transmission is efficient in waterfowl, as the virus can persist in water sources for extended periods [34]. Mechanical vectors, including fomites, contaminated equipment, and wild birds, contribute to spread. Vertical transmission (egg-borne) has not been definitively demonstrated [16]. Outbreaks have been documented in vaccinated flocks, indicating that vaccine failure or antigenic drift may occur [1]. Non-target species such as chickens and turkeys are generally refractory to disease but can seroconvert after exposure to high doses of virus or recombinant vaccine vectors [17, 18, 19]. The epidemiology of DVE is further complicated by the existence of attenuated vaccine strains that may revert to virulence or recombine with field strains [14, 20]. A recent outbreak in a vaccinated duck flock in China was linked to a virulent strain that was closely related to the vaccine parent strain, suggesting possible recombination or reversion [1]. For comparison with other poultry herpesviruses, see Marek's Disease Virus Vaccine Strains.

Clinical Signs

The clinical presentation of DVE ranges from peracute death to a subacute or chronic form depending on the virulence of the strain, host age, and immune status [1, 34]. Peracute cases exhibit sudden death with few premonitory signs, often within 24–48 hours of exposure [34]. Acute disease is characterized by depression, ruffled feathers, anorexia, photophobia, polydipsia, and severe watery diarrhea [1, 33]. Ocular and nasal discharges are common. Birds may develop ataxia, weakness, and prostration. In laying ducks, egg production drops precipitously [34].

Hemorrhagic lesions are pathognomonic. The vent may be soiled with blood-stained feces. Swollen, edematous eyelids and conjunctivitis are frequently observed [1]. In the terminal stages, birds may exhibit convulsions or opisthotonos [34]. Mortality rates in naïve flocks can approach 100% [1]. Subacute cases show milder signs with lower mortality, often in partially immune populations [14]. Chronic infection is associated with persistent viral shedding and poor growth performance [5]. The clinical presentation must be differentiated from other causes of hemorrhagic enteritis in waterfowl, such as salmonellosis, colibacillosis, and Riemerella anatipestifer infection (see Riemerella anatipestifer Infection in Ducks: Septicemia and Serositis).

Pathology

Gross pathological findings in DVE are dominated by vascular damage and hemorrhages [1, 34]. The most characteristic lesion is the presence of hemorrhagic annular bands in the lumen of the esophagus and intestine. The esophagus may show linear hemorrhages and diphtheritic membranes [34]. The intestinal tract exhibits severe catarrhal or hemorrhagic enteritis, with petechiation and ecchymoses on the serosal surfaces. The liver is enlarged, friable, and may contain pale necrotic foci (2–5 mm in diameter) surrounded by hemorrhagic rings [1, 15]. The spleen is often enlarged and mottled. The bursa of Fabricius may show hemorrhages and necrosis. In laying birds, ovarian follicles may be hemorrhagic and degenerated [34].

Histopathological examination reveals necrosis of hepatocytes, degeneration of intestinal epithelial cells, and intranuclear inclusion bodies characteristic of herpesvirus infection [1, 33]. The esophagus and cloaca show severe necrosis of the mucosal epithelium with infiltration of heterophils and lymphocytes. Lymphoid organs, including the spleen and bursa, display lymphoid depletion and necrosis [34]. Hepatic lesions include eosinophilic intranuclear inclusions in hepatocytes and Kupffer cells [1]. Ultrastructural studies reveal viral particles within the nucleus and cytoplasm of infected cells [32]. The host actin-myosin II network is hijacked for viral egress, as demonstrated by proteomic screening for targets of the VP26 protein [21]. Virulence attenuation via combined gene deletion has been shown to restore gut microbiota balance and reduce intestinal pathology [14].

Diagnostics

Rapid and accurate diagnosis of DVE is critical for outbreak management. Diagnostic approaches include clinical observation, gross pathology, histopathology, virus isolation, and molecular detection methods. See the accompanying diagnostic workflow in Figure 1.

flowchart TD
    A[Suspected DVE case], > B{Clinical signs & PM lesions}
    B, >|Hemorrhagic enteritis, esophageal bands, liver necrosis| C[Collect samples: liver, spleen, intestinal mucosa, cloacal swabs]
    C, > D[Laboratory testing]
    D, > E{Virus isolation in CEF or duck embryo fibroblasts}
    E, >|CPE observed| F[Confirm by PCR or sequencing]
    D, > G{Molecular detection}
    G, >|Conventional PCR| H[Amplify UL2, UL50, or gC genes]
    G, >|Real-time PCR / rtRPA| I[Quantify viral load]
    G, >|MIRA-based assays| J[Rapid isothermal detection]
    D, > K{Serology}
    K, >|ELISA / virus neutralization| L[Detect antibodies in recovered birds]
    E, >|No CPE| M[Report negative; consider other enteric viruses]
    H, > N[Sequence analysis for strain typing]
    I, > N
    J, > O[Point-of-care diagnosis]
    N, > P[Phylogenetic comparison with known strains]
    P, > Q[Determine virulence markers]

Figure 1. Diagnostic workflow for duck viral enteritis.

Clinical and pathological diagnosis: The presence of esophageal hemorrhagic bands, hepatic necrosis, and hemorrhagic enteritis in waterfowl is highly suggestive of DVE [1, 34]. However, these lesions are not pathognomonic, and confirmatory testing is required.

Virus isolation: Tissue samples (liver, spleen, intestine) are homogenized and inoculated onto duck embryo fibroblasts or CEF. Cytopathic effects typically appear within 48–96 hours post-inoculation [1, 12]. The isolate can be confirmed by electron microscopy or molecular methods [6].

Molecular diagnostics: Several PCR-based assays are available. Conventional PCR targeting genes such as UL2, UL50, or the glycoprotein C gene is widely used [16, 22]. Real-time recombinase polymerase amplification (rtRPA) assays provide rapid detection with high sensitivity and specificity [16]. More recent methods include multienzyme isothermal rapid amplification (MIRA) combined with quantitative PCR (MIRA-qPCR) or lateral flow dipsticks (MIRA-LFD) for rapid, instrument-free detection [22]. These methods can differentiate virulent from vaccine strains when combined with sequencing [16]. Real-time PCR assays remain the gold standard for quantitation of viral load in tissues and swabs [33].

Serology: Serum neutralization tests and enzyme-linked immunosorbent assays (ELISAs) are used to detect antibodies in recovered or vaccinated birds. These assays are less useful for acute diagnosis but are valuable for epidemiological surveillance [12, 33].

Newer technologies: Recombinant DEV vectors have been developed that express reporter genes, aiding in diagnostic differentiation [23, 24, 31]. In situ hybridization and immunohistochemistry can localize viral antigens in tissues [1].

Treatment and Management

There is no specific antiviral therapy approved for DVE in waterfowl. Supportive care, including fluid and electrolyte therapy, may reduce mortality in valuable individual birds but is impractical in commercial flocks [25]. Experimental evidence suggests that piperazine may inhibit DEV replication by modulating host cytokine responses, but this has not been translated to clinical practice [26]. Chlorogenic acid, a plant polyphenol, has been shown to modulate gene expression in DEV-infected duck embryo fibroblasts, but in vivo efficacy remains unproven [13]. Poly I:C, a synthetic double-stranded RNA analog, alleviated intestinal injury in DEV-infected ducks by inhibiting apoptosis in experimental studies [25]. These interventions are not currently recommended for routine use.

Management of an outbreak focuses on rapid containment. Affected facilities must be quarantined immediately. The movement of birds, personnel, equipment, and feed should be restricted [34]. Infected flocks may be depopulated to prevent further spread. Carcasses should be disposed of by incineration or deep burial. Thorough cleaning and disinfection of premises with lipid-solvent disinfectants (e.g., phenolics, formaldehyde, or sodium hypochlorite) is essential [34]. Re-stocking should be delayed until sentinel birds remain free of disease for at least 21 days [34].

Control and Prevention

Vaccination is the cornerstone of DVE control in commercial duck flocks. Live attenuated vaccines, typically generated by serial passage in chicken embryo fibroblasts or duck embryo cells, are widely used [14, 12, 20]. These vaccines provide robust immunity, but breakthrough infections have been reported, necessitating periodic strain matching [1, 15]. Marker vaccines with deletions in genes such as ICP27 or UL2 allow differentiation between infected and vaccinated animals (DIVA strategy) [5, 20]. Recombinant DEV vectored vaccines expressing antigens from other pathogens (e.g., duck hepatitis A virus, Pasteurella multocida OmpH, influenza hemagglutinin, Chlamydia psittaci Pmp17G, and goose astrovirus Cap protein) offer dual protection against DVE and the target disease [23, 27, 24, 28, 30, 31]. CRISPR/Cas9 gene editing has been employed to construct recombinant DEV vaccines with improved safety and immunogenicity [28, 31]. The current status of recombinant DEV vector vaccine research has been extensively reviewed [3].

Vaccination protocols vary by region. In enzootic areas, breeders are vaccinated prior to the laying period to provide maternal antibody to ducklings. Grow-out flocks may receive a single vaccination at 1–3 days of age or a booster at 4–6 weeks [3, 12]. Attenuated vaccines must be used with caution in non-target species and wild birds, as horizontal transmission and residual pathogenicity have been documented [17, 18, 19].

Biosecurity measures are essential for prevention. Facilities should be located away from wild waterfowl habitats. All-in/all-out production systems reduce the risk of residual infection. Footbaths, dedicated equipment, and rodent control are standard. Quarantine of new introductions before mixing with the resident flock is mandatory [34]. Serological monitoring can detect subclinical circulation of DEV [33].

Regulatory control: In many countries, DVE is a notifiable disease. Outbreaks must be reported to veterinary authorities. Control programs may include stamping out, movement restrictions, and vaccination campaigns in high-risk areas [34]. For discussion on how viral enteritis management principles relate to other species, see Therapeutic Interventions and Fluid Therapy for Canine Parvovirus and Viral Enteritis. For broader context on waterfowl health, consult Duck Diseases: A Comprehensive Overview.

Conclusion

Duck viral enteritis remains a major threat to waterfowl health globally. An understanding of the viral genetics, host-pathogen interactions, and clinical disease course is essential for effective management. Advances in molecular diagnostics, including isothermal amplification and real-time PCR, facilitate rapid detection and strain characterization. Vaccination, combined with strict biosecurity, offers the most effective control strategy. Continued surveillance and research into novel vaccines and therapeutic agents are needed to combat emerging virulent variants and prevent outbreaks in both commercial and wild settings.

References

[1] Sang S, Wang H, Dan Y, et al. Isolation, identification and pathogenicity analysis of a virulent duck enteritis virus strain causing outbreak in vaccinated duck flocks. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42322961/

[2] Yasmin L, Siddique MS, Islam T, et al. Complete genome sequence of a virulent duck enteritis virus isolated from Northern part of Bangladesh. Microbiol Resour Announc. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41134219/

[3] Jia WF, Wang AP, Wu Z, et al. Current status of recombinant duck enteritis virus vector vaccine research. Front Vet Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39974164/

[4] Yang H, Zhang B, Yang X, et al. Complete genome sequence and biological characteristics of a novel duck enteritis virus variant with a deletion in UL2. Arch Virol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40991013/

[5] Yin D, Gao Y, Xu M, et al. Pathogenic mechanisms and molecular features of a novel UL2 gene-deficient duck enteritis virus endemic to China. Virulence. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40801158/

[6] Huo SX, Zhu YC, Chen L, et al. Complete Genome Sequence and Construction of an Infectious Bacterial Artificial Chromosome Clone of a Virulent Duck Enteritis Virus Strain XJ. Transbound Emerg Dis. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/40303036/

[7] Huo SX, Chen L, Bao ED, et al. Functional characterization of UL50 gene reveals its essential role in duck enteritis virus replication and pathogenesis. Vet Q. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41876382/

[8] Ruan P, Chen Y, Wang M, et al. Duck plague virus UL24 protein initiates K48/K63-linked IRF7 polyubiquitination to antagonize the innate immune response. Poult Sci. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39418790/

[9] Gao L, Liu R, Yang F, et al. Duck Enteritis Virus Inhibits the cGAS-STING DNA-Sensing Pathway To Evade the Innate Immune Response. J Virol. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/36448809/

[10] Liu R, Gao L, Yang F, et al. Duck Enteritis Virus Protein Kinase US3 Inhibits DNA Sensing Signaling by Phosphorylating Interferon Regulatory Factor 7. Microbiol Spectr.

[11] Huang J, Wang M, Cheng A, et al. Duck enteritis virus LORF4 gene is a late gene and nonessential for virus replication in vitro. Poult Sci. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39288717/

[12] Dandapat S, Bindu S, Sharma GK, et al. Development and evaluation of a chicken embryo fibroblast cell culture based live attenuated Indian strain duck plague vaccine. Vet Q. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38726839/

[13] Yang Y, Zhang Q, Cai H, et al. RNA-seq analysis of chlorogenic acid intervention in duck embryo fibroblasts infected with duck plague virus. Virol J. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38454409/

[14] Kong J, Han C, Shao G, et al. Virulence attenuation of intestinal pathogenicity via combined gene deletion in duck enteritis vaccine strain restores gut microbiota balance and enhances safety. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41764962/

[15] Guo Z, Zhang S, Sun Y, et al. Genomic characteristics, pathogenicity and viral shedding of a novel DVEV variant derived from goose. Poult Sci. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/36745957/

[16] Wan J, Zhu Y, Xu X, et al. Development of a rapid detection method for a virulent strain of duck enteritis virus based on real-time fluorescence recombinase polymerase amplification. Sheng Wu Gong Cheng Xue Bao. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42009547/

[17] Abdulrahim Y, You Y, Wang L, et al. Correction: Abdulrahim et al. Evaluation of Tissue Tropism and Horizontal Transmission of a Duck Enteritis Virus Vectored Vaccine in One-Day-Old Chicken. Viruses. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39772278/

[18] Abdulrahim Y, You Y, Wang L, et al. Evaluation of Tissue Tropism and Horizontal Transmission of a Duck Enteritis Virus Vectored Vaccine in One-Day-Old Chicken. Viruses. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39599796/

[19] Kong J, Feng K, Zhao Q, et al. Pathogenicity and transmissibility studies on live attenuated duck enteritis virus vaccine in non-target species. Front Microbiol. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/36439841/

[20] Wu Y, Liu L, Zhang M, et al. A Recombinant Duck Plague Virus Containing the ICP27 Deletion Marker Provides Robust Protection in Ducks. Microbiol Spectr. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37404171/

[21] Chen L, Zhu YC, Yun T, et al. Proteomic Screening for Cellular Targets of the Duck Enteritis Virus Protein VP26 Reveals That the Host Actin-Myosin II Network Regulates the Proliferation of the Virus. Int J Mol Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41009665/

[22] Dai Y, Hu X, Zhong Y, et al. Rapid Detection of Duck Enteritis Virus with MIRA, MIRA-qPCR, and MIRA-LFD Assays. Pathogens. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41156591/

[23] Jia W, Wang A, Wu Z, et al. Construction and characterization of recombinant duck enteritis virus expressing duck hepatitis A virus 3 immunogenic genes. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41850054/

[24] Chen L, Zhu Y, Yun T, et al. In vitro expression of the goose astrovirus Cap protein delivered with a duck enteritis virus vector. BMC Vet Res. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40317044/

[25] Zhang Y, Wu Y, Zhang X, et al. Poly I: C Alleviated Duck Intestinal Injury Infected with Duck Viral Enteritis by Inhibiting Apoptosis. Curr Microbiol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39105989/

[26] Bhattacharya S, Kumar S. Piperazine inhibits Anatid herpesvirus-1 infection by possible modulation of host cytokines. Microb Pathog. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40484049/

[27] Zhao Y, Ma Q, Jiao C, et al. Recombinant duck enteritis virus harboring the hemagglutinin genes of influenza virus rapidly induces specific cellular immunity in ducks. J Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41467842/

[28] Liu J, Wang Y, Tang N, et al. CRISPR/Cas9-edited duck enteritis virus expressing Pmp17G of Chlamydia psittaci induced protective immunity in ducklings. Pathog Dis. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39400699/

[29] Shi X, Zhuang H, Shuo D, et al. Pathogenicity Evaluation and Virulence Gene Identification of an Attenuated Duck Enteritis Virus. Microorganisms. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41304222/